{"id":26607,"date":"2014-09-08T09:37:12","date_gmt":"2014-09-08T07:37:12","guid":{"rendered":"https:\/\/www.rudebaguette.com\/?p=26607"},"modified":"2014-09-08T09:37:12","modified_gmt":"2014-09-08T07:37:12","slug":"carmat-confirms-2nd-successful-transplant-artificial-heart-france","status":"publish","type":"post","link":"https:\/\/www.rudebaguette.com\/en\/2014\/09\/carmat-confirms-2nd-successful-transplant-artificial-heart-france\/","title":{"rendered":"Carmat has transplanted its artificial heart into a second patient"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-full wp-image-24120\" src=\"https:\/\/www.rudebaguette.com\/assets\/carmat-3.jpeg\" alt=\"carmat-3\" width=\"858\" height=\"429\" \/><\/p>\n<p>After rumors began to circulate last week that Carmat, the medical technology startup building the first fully autonomous artificial heart, had\u00a0performed a 2nd operation on a patient in the\u00a0Nantes, the company\u00a0<a href=\"http:\/\/www.lesechos.fr\/industrie-services\/pharmacie-sante\/0203756125758-carmat-confirme-limplantation-du-second-coeur-artificiel-1040179.php?xtor=RSS37\" target=\"_blank\" rel=\"noopener\">confirmed<\/a>\u00a0the information this week, stating that the operation appeared successful thus far. Little is known about the patient&#8217;s identity at the time; however,\u00a0the requirements of the procedure are that the patient\u00a0have impending terminal heart failure. The previous patient, 76 year-old\u00a0Claude Dany,\u00a0had a life expectancy of less than week.<\/p>\n<p>Despite living 74 days beyond the operation, the death of Carmat&#8217;s first of four required test patients (before extend experiments can begin) posed a big problem for Carmat, as the cause of death was determined to be a problem associated with Carmat&#8217;s heart. This second surgery would suggest that Carmat is confident they have identified the source of the issue and resolved it.\u00a0Their hope with the first patient was that he live at least 30 days, so it is not unreasonable to expect that the next patient live at least 100 days beyond the surgery (save an unrelated cause of death).<\/p>\n<p>France&#8217;s medical device industry is quite expansive, due largely to France&#8217;s welcoming healthcare industry, as we discovered earlier this year <a href=\"https:\/\/www.rudebaguette.com\/2014\/03\/20\/sofinnova-partners-katie-ellias-french-startups-disrupting-medical-device-industry\/\">in an interview with Sofinnova senior associate\u00a0Katie Ellias<\/a>. I also spoke\u00a0this past June with Carmat&#8217;s chairman at <a href=\"http:\/\/Lafrenchtouchconference.net\" target=\"_blank\" rel=\"noopener\">LFTC<\/a>, amidst much of the controversy over the cause of death of their first patient &#8211; he seemed calm and collected, and he spoke passionately of his work.<\/p>\n<p>One of the most amazing\u00a0aspects of Carmat is not just the life-saving aspect, but the job-creation side. Currently, the lack of supply of organ donor hearts means that the\u00a0surgeon community can only support so many heart surgeons, like Carmat Co-founder Alain\u00a0Carpentier; however, if artificial hearts could be manufactured in the millions,\u00a0then not only could the\u00a0tens of thousands of patients on standby for a heart transplant at any given moment receive said transplant, but the need for heart surgeons would increase 100-fold.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>After rumors began to circulate last week that Carmat, the medical technology startup building the first fully autonomous artificial heart, had\u00a0performed a 2nd operation on a patient in the\u00a0Nantes, the company\u00a0confirmed\u00a0the information this week, stating that the operation appeared successful thus far. Little is known about the patient&#8217;s identity at the time; however,\u00a0the requirements of<\/p>\n","protected":false},"author":77,"featured_media":24120,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"subtitle":"","footnotes":""},"categories":[10563],"tags":[],"class_list":["post-26607","post","type-post","status-publish","format-standard","has-post-thumbnail","category-tech"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/posts\/26607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/comments?post=26607"}],"version-history":[{"count":0,"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/posts\/26607\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/media\/24120"}],"wp:attachment":[{"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/media?parent=26607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/categories?post=26607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rudebaguette.com\/en\/wp-json\/wp\/v2\/tags?post=26607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}